Top Thrombocytopenia Companies in Vietnam | Key Players 2026

Top Thrombocytopenia Companies in Vietnam

The following is a data-backed list of the leading Vietnam Thrombocytopenia companies, compiled through 6Wresearch's proprietary research and validated by in-house industry analysts. These companies represent the key players shaping competition in the Vietnam Thrombocytopenia Industry, including Novartis, Pfizer, and other established names.

List of Thrombocytopenia companies in Vietnam:

1. Novartis

Novartis is a prominent healthcare company providing advanced therapeutic options and treatments for various blood-related conditions and disorders.

2. Pfizer

Pfizer is sought after for its global medical research, offering innovative specialty medicines that address complex haematological conditions.

3. Roche

A premier global healthcare company delivering specialized diagnostic tools and therapeutics designed to support clinical management.

4. Sanofi

A specialized life sciences organization focusing on rare blood disorders and innovative therapeutic interventions for patients.

5. Takeda Pharmaceutical

A global biopharmaceutical leader delivering specialized plasma-derived therapies and haematology treatments across professional clinical networks.

6. Amgen

Amgen plays a significant role in developing targeted biologic treatments that support advanced care protocols within the haematology sector.

7. Sobi (Swedish Orphan Biovitrum)

Sobi is increasingly represented in specialized care channels, catering to clinicians looking for innovative treatments for rare hematologic conditions.

8. Rigel Pharmaceuticals

Gaining traction through specialty medical channels for developing targeted oral therapies aimed at chronic immune hematologic diseases.

9. Kyowa Kirin

Known for its advanced antibody technologies, it provides specialized therapeutic options for complex blood disorders.

Frequently Asked Questions About the Market Study (FAQs):